Concord Wealth Partners Johnson & Johnson Transaction History
Concord Wealth Partners
- $603 Million
- Q4 2024
A detailed history of Concord Wealth Partners transactions in Johnson & Johnson stock. As of the latest transaction made, Concord Wealth Partners holds 23,216 shares of JNJ stock, worth $3.55 Million. This represents 0.56% of its overall portfolio holdings.
Number of Shares
23,216
Previous 26,740
13.18%
Holding current value
$3.55 Million
Previous $4.33 Million
22.52%
% of portfolio
0.56%
Previous 0.73%
Shares
19 transactions
Others Institutions Holding JNJ
# of Institutions
4,356Shares Held
1.69BCall Options Held
17.7MPut Options Held
14.6M-
Vanguard Group Inc Valley Forge, PA231MShares$35.4 Billion0.69% of portfolio
-
Black Rock Inc. New York, NY198MShares$30.3 Billion0.67% of portfolio
-
State Street Corp Boston, MA134MShares$20.6 Billion0.9% of portfolio
-
Geode Capital Management, LLC Boston, MA56.1MShares$8.59 Billion0.75% of portfolio
-
Morgan Stanley New York, NY45.2MShares$6.92 Billion0.54% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $400B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...